DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 190 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $387,220 | -74.9% | 39,472 | -72.8% | 0.01% | -66.7% |
Q4 2022 | $1,542,619 | +35.2% | 144,983 | +32.6% | 0.03% | +42.1% |
Q3 2022 | $1,141,000 | +555.7% | 109,334 | +579.9% | 0.02% | +533.3% |
Q1 2022 | $174,000 | -75.0% | 16,080 | -67.6% | 0.00% | -83.3% |
Q4 2021 | $697,000 | -26.8% | 49,570 | 0.0% | 0.02% | +5.9% |
Q3 2021 | $952,000 | +16.4% | 49,570 | -40.4% | 0.02% | +21.4% |
Q1 2021 | $818,000 | +60.1% | 83,183 | -29.7% | 0.01% | -6.7% |
Q3 2020 | $511,000 | -49.0% | 118,300 | +4.8% | 0.02% | -68.8% |
Q2 2020 | $1,001,000 | – | 112,900 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |